Organigram, a Canadian marijuana company that recently partnered with a subsidiary of cigarette maker British American…
Why cannabis producer Organigram struck a CA$220 million deal with a tobacco giant: Q&A with CEO Greg Engel
While rival Canadian cannabis producers plowed massive amounts of capital into cultivation infrastructure, losing billions of…
British American Tobacco strikes deal with Canada’s Organigram, portending similar tie-ups with US marijuana firms
An Organigram grow room. (This story has been updated with analysis and more details.) A subsidiary…
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
A look inside GW Pharmaceuticals' production process. The company recently agreed to a $7.2 billion acquisition.…
New cannabis beverage council drawing inspiration from alcohol prohibition to boost segment
The American Trade Association for Cannabis and Hemp, an industry trade and advocacy organization, has formed…
Organigram revenue stalls on erratic inventory, unfulfilled demand
New Brunswick-based cannabis producer Organigram continues to struggle, reporting lower sales and a bigger loss for…